Neuro 2 Flashcards
(39 cards)
what is Huntington’s disease
autosomal dominant neurodegenerative disorder characterized by involuntary choreatic movements with cognitive and behavioral disturbances
pathophys of Huntington disease
CAG repeats on chromosome 4
when do sx usually begin for huntington
30-50
sx huntington
3 hallmarks - mood, movement, memory - behavioral and mood changes, chorea (rapid involuntary movements), dementia
chorea - face, neck, trunk, limbs - may disappear during sleep and worse with stress and voluntary movements
PE huntington
restlessness, fragility
quick, involuntary hand movements
brisk DTR
dx huntington
clinical sx + FHx + genetic confirmation
CT or MRI - cerebral and striata (caudate nucleus and putamen) atrophy with subsequent widening in the frontal horns of the lateral ventricle (boxcar ventricle sign)
tx huntington
no cure - usually fatal within 15-20 years after presentation
tetrabenazine for dyskinesia or chorea
antidopaminergics - typical and atypical antipsychotics
benzos intermittently may help w chorea and sleep, esp during stressful situations
what is essential tremor
autosomal dominant disorder
incidence increases w age
sx essential tremor
intuitional tremor - postural b/l action tremor most commonly affecting the upper extremities and head (hands, forearms, head, neck, voice)
tremor worsened with action and intentional movement, postural - holding affected body part against gravity, adrenergic activity - stress, anxiety
tremor improved with alcohol ingestion, when body part is supported, at rest
PE essential tremor
more pronounced with arms suspended against gravity in a fixed posture
during goal-directed activity (finger to nose testing) the tremor increases at the end of approaching the target or holding a position against gravity
may see cogwheel phenomenon
dx essential tremor
dx of exclusion based on history, FHx, physical exam
tx essential tremor
no needed if mild
first line - propranolol - first line - or primidone (barb) if no relief w propranolol
parkinson disease
neurodegenerative movement disorder due to decreased dopamine resulting from idiopathic loss of dopaminergic neurons in the striatum and substantia nigra and the presence of Lewy bodies
pathophys Parkinson
decreased dopamine –> imbalance of dopamine and acetylcholine –> improper movement due to failure of acetylcholine inhibition in basal ganglia
eosinophilic cytoplasmic inclusions (Lewy bodies) and loss of pigment cells in substantia nigra
sx parkinson
motor triad - -resting tremor, bradykinesia, muscle rigidity
resting tremor - pill-rolling; worse at rest, emotional stress, excitement, walking; better with voluntary activity, intentional movement, sleep
cogwheel rigidity
postural instability - stooped posture and loss of postural reflexes
loss of smell (anosmia), mood disorders (depression), constipation, excess salivation or drooling (sialorrhea), sleep dysfunction
PE parkinson
normal DTRs
no weakness
face involvement - fixed facial expression
myerson’s sign - tapping bridge of nose causes a sustained blink
postural instability - pull test - standing behind patient and pulling the shoulders causes the patient to fall or take steps backwards
tx parkinson
levodopa-carbidopa - most effective
dopamine agonists - bromocriptine, pramipexole, ropinirole); can be used to delay use of levodopa in younger patients
Guillain barre
group of conditions due to acquired autoimmune-mediated demyelinating polyradiculopathy of the peripheral NS characterized by rapidly evolving muscular weakness
most common cause of Guillain barre
campylobacter jejune MC
other antecedent GI or respiratory infections - influenza A and B
pathophys Guillain barre
molecular mimicry –> autoantibodies attack schwwann cells
sx Guillain barre
symmetric, ascending, progressive, flaccid muscle weakness and sensory changes (paresthesias, pain)
cranial nerve and bulbar sx - cranial nerves 3, 4, 6
weakness of respiratory muscles
sensory involvement - paresthesias, pain, cramps
PE Guillain barre
LMN signs - decreased DTR
sensory deficits and cranial nerve palsies (3, 4, 6)
autonomic dysfunction - tachycardia, arrhythmias, hypotension, HTN, breathing difficulties
dx Guillain barre
electrophysiologic studies - decreased motor nerve conduction velocities and amplitude
CSF analysis - high protein with normal WBC
autoantibodies - anti-GM1, anti-GD1A, anti-GT1A, anti-GQ1B
PFTs - decreased peak inspiratory pressure and forced vital capacity
tx Guillain barre
plasmphaeresis or IVIG first line for antibody removal
prednisone not indicated